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http:WHAT THIS PAPER ADDS
Acute thromboembolic occlusion of the superior mesenteric artery (SMA) is a life-threatening disease. Despite
advances in surgical technique, mortality remains high. The results of our study indicate that percutaneous
revascularization is a promising alternative to surgical reconstruction in selected patients who present with
acute occlusion of the SMA.Objective: To evaluate our early experience with endovascular revascularization in patients with acute
thromboembolic occlusion of the superior mesenteric artery (SMA).
Methods: A retrospective review was conducted of all patients who underwent endovascular revascularization
for acute thromboembolic SMA occlusion from May 2005 to May 2012. Endovascular revascularization was
performed using aspiration, intra-arterial thrombolysis, and adjunctive stent-placement techniques. Laparotomy
was performed if the patient developed clinical signs of advanced bowel ischemia after endovascular procedure.
Results: Twenty-one patients underwent endovascular revascularization for acute thromboembolic SMA
occlusion. All presented with acute-onset abdominal pain. Three patients had rebound tenderness before the
procedure. Computed tomography angiography revealed complete occlusion in seven cases and incomplete
occlusion in 14 cases, with no evidence of free gas or bowel necrosis. The median duration from onset of
symptoms to revascularization was 8.7  4.1 hours (range, 2e18 hours). Completely successful endovascular
revascularization occurred in six cases (aspiration alone, 3 cases; combined aspiration and urokinase, 3 cases);
partial success was achieved in 15 cases (aspiration alone, 4 cases; combined aspiration and urokinase, 10 cases;
and combined aspiration, urokinase, and stent placement, 1 case). Laparotomy was required in ﬁve patients, all
of whom had SMA main trunk complete occlusion and required small bowel resection. The 30-day mortality for
all patients was 9.5%. During a median follow-up of 26 months, 15 patients remained asymptomatic, three
patients reported occasional abdominal pain, and one patient had temporary short-bowel syndrome.
Conclusions: Percutaneous revascularization is a promising alternative to surgery for acute SMA occlusion in
selected patients who have no signs of advanced bowel ischemia. Early diagnosis followed by prompt
endovascular intervention with close postprocedural monitoring is key. Laparotomy is indicated in patients who
develop new or worsening signs of peritonism after endovascular procedure, particularly in those who had
complete occlusion of the main trunk of the SMA.
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//dx.doi.org/10.1016/j.ejvs.2013.09.025Early diagnosis and prompt treatment are necessary to
prevent bowel ischemia and subsequent bowel infarction,
necrosis, or perforation.1e5 Surgery is associated with a high
rate of morbidity and mortality.1,6,7 Endovascular tech-
niques may be a better treatment option, as they carry a
lower risk of morbidity; however, data supporting the use of
these techniques are currently lacking.
The purpose of this study was to evaluate our early
experience with an endovascular technique to re-establish
perfusion to the bowel in patients who suffered from
acute thromboembolic occlusion of the SMA.
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Study design
This retrospective study was approved by our institutional
review board. All patients who underwent endovascular
revascularization for the treatment of acute thromboem-
bolic occlusion of the SMA at our institution from May 2005
to May 2012 were included. Cases were identiﬁed through
our departmental procedural log. Patient demographics,
clinical information, and procedural data were gathered
from patients’ medical records.
Diagnostic workup
When acute SMA occlusion was suspected, patients un-
derwent computed tomography angiography (CTA). Digital
subtraction angiography (DSA) was then performed in those
patients who were considered candidates for endovascular
intervention. The ﬁndings of the CTA and DSA were used to
assess the number and location of embolic occlusions.
Indications for endovascular revascularization
Endovascular revascularization was indicated when there
was CTA evidence of acute occlusion of the SMA (either the
main trunk or branch) and when there was no clinical or
imaging evidence of advanced bowel ischemia. Patients
therefore did not undergo endovascular intervention if they
had abdominal rigidity, marked abdominal distension with
scarce bowel sounds, hypovolemic or septic shock,
abdominal free air, pneumatosis intestinalis, or air bubbles
in the mesenteric veins on CT scan.
Techniques of endovascular revascularization
Conventional mesenteric arteriography was performed
before endovascular therapy. A 5-Fr sheath was introduced
through a femoral approach. A bolus of 3,000 to 5,000 units
of heparin was immediately administered through the
sheath, followed by 1,000 units per hour continuously
during the procedure, with control of activated clotting time
(target: approximately 200 seconds). The SMA was cannu-
lated with a 5-Fr Cobra catheter, and selective superior
mesenteric arteriography was performed in posterior-
anterior and lateral projections. Once SMA occlusion was
conﬁrmed, the 5-Fr sheath was exchanged for an 8-Fr
sheath. An 8-Fr guiding catheter (Vista Brite Tip Guiding
Catheter, Johnson & Johnson Co. Ltd., Miami, FL, USA) was
advanced through the 8-Fr sheath, with the curved tip
placed at the oriﬁce of the SMA. A 0.035-inch hydrophilic
guide wire was then passed beyond the mesenteric occlu-
sion. With the wire in place, a 6-Fr guiding catheter (Envoy
Guiding Catheter, Johnson & Johnson Co. Ltd., New Bruns-
wick, NJ, USA) was co-axially advanced through the 8-Fr
guiding catheter past the occlusion. The guide wire was
then removed, and thrombectomy was performed by
aspirating through the 6-Fr guiding catheter with a 50-mL
syringe while gradually pulling the guiding catheter out.
This process was repeated multiple times as needed until
the embolus was completely removed or further removal ofthe emboli was not possible. For disease in SMA branches, a
5-Fr catheter (Beacon Tip Torcon NB Advantage Catheter,
Cook Co. Ltd., Bloomington, IN, USA) was used for
aspiration.
Pharmacologic thrombolysis was indicated if there was
inadequate contrast ﬂow to the corresponding bowel
because of residual thromboemboli. A 4-Fr infusion cath-
eter (Uni*Fuse Infusion System, Angio Dynamics Co. Ltd.,
Latham, NY, USA) or a microcatheter (Progreat Micro-
catheter System, Terumo, Tokyo, Japan) was advanced just
above the thromboembolic occlusion of the main trunk or
branch, respectively, and a bolus of urokinase (e.g., 200,000
to 400,000 units) was slowly injected over 10 to 20 minutes.
Direct intra-arterial administration of prostaglandin E1 was
indicated when vascular spasm occurred. If residual luminal
narrowing was greater than 75% because of underlying
atherosclerosis, an adjunctive stent was placed.
Technical success of endovascular revascularization was
deﬁned as residual stenosis of the previously occluded ar-
tery of less than 30% in diameter, without migration of
small thromboemboli to branches, along with prompt ﬂow
and visible contrast reaching the entire bowel. Partial suc-
cess was deﬁned as re-established or improved ﬂow to the
corresponding bowel but with residual luminal caliber
greater than 30% or occurrence of small thromboemboli
migration to distal vessels.8,9
Postprocedure care
After the endovascular procedure, all patients were
admitted to the intensive care unit for close monitoring of
potential worsening of mesenteric ischemia or complica-
tions from the procedure. All cases were managed with
bowel rest, nasogastric drainage, intravenous ﬂuid therapy,
and nutritional support. Laparotomy was indicated if
abdominal pain worsened or if the patient developed new
symptoms or signs suggestive of bowel perforation and/or
gangrene. If bowel perforation or gangrene was found
during laparotomy, a bowel resection was performed. Re-
look laparotomy was performed if there was further clin-
ical deterioration after bowel resection.
Subcutaneous low molecular weight heparin was
administered routinely (low molecular weight heparin cal-
cium injection, 0.1 mL/10 kg every 12 hours, GlaxoSmithK-
line Co. Ltd., London, UK) for 3 days. Warfarin was
administered once the abdominal pain associated with
bowel ischemia had resolved. Patients who had signiﬁcant
atherosclerotic disease (in the aorta and/or SMA) or who
had received a metal stent were treated with antiplatelet
therapy (oral clopidogrel 75 mg/day for 3 months and
aspirin 100 mg/day for at least 1 year).
All patients who were treated with endovascular therapy
underwent echocardiography to exclude a cardiac
embolism.
Clinical follow-up
Outpatient clinic visits were offered at 1, 2, and 6 months
during the ﬁrst year and annually thereafter for follow-up of
198 Z. Jia et al.abdominal pain (onset, duration, severity, and relation to
meals) and other potential complications such as short-
bowel syndrome (malabsorption, diarrhea, steatorrhea,
ﬂuid and electrolyte disturbances, and malnutrition). Pa-
tients who exhibited abdominal pain underwent CTA of the
SMA. Telephone interviews were conducted if patients
failed to return for a clinical visit.
RESULTS
From May 2005 to May 2012, a total of 28 patients pre-
sented to our emergency room with acute abdominal pain
and were subsequently diagnosed with acute thromboem-
bolic SMA occlusion. Of the 28 patients, 21 had no clinical
or CT evidence of advanced bowel ischemia and were
treated with endovascular techniques. The seven patients
who were not treated with endovascular revascularization
were excluded because of evidence of advanced bowel
ischemia on physical examination, including abdominal ri-
gidity on physical examination (n ¼ 7); abdominal disten-
sion and scarce bowel sounds (n ¼ 4); shock upon initial
presentation (n ¼ 1); intestinal expansion, gas, and ﬂuid
gathering (n ¼ 4); and peritoneal effusion (n ¼ 3). None of
these patients had free air and pneumatosis intestinalis
on CT.
Table 1 summarizes the clinical characteristics, treat-
ments, and outcomes for the 21 patients who underwent
percutaneous endovascular therapy. The patient group
included 15 men and six women with a median age of 71
years (range, 54e87 years). The median duration from
onset of symptoms to endovascular intervention was
8.7  4.1 hours (range, 2e18 hours). Of the 21 patients, 15
(71.4%) had elevated neutrophils and 14 (66.7%) had
elevated D-dimer on admission. A total of 15 (71.4%) pa-
tients had atrial ﬁbrillation (AF); among these patients, 12
(80%) had received anticoagulant therapy, but only three of
the 12 (25%) had achieved therapeutic levels with inter-
national normalized ratio on admission (range, 2.0e3.0). In
the three patients with AF who did not receive anti-
coagulation therapy, one was found to have thrombus in
the left atrium on echocardiography, and two had a history
of peripheral arterial embolism (1.2 and 3 years before
presentation). Echocardiography was performed in all 21
patients, and no evidence was found of atrial septal defect
or ventricular septal defect.
All 21 cases demonstrated thromboembolic SMA occlu-
sion on both CTA and DSA, and all patients had single vessel
occlusion. There were 17 main trunk occlusions (5 complete
and 12 incomplete) and four branch occlusions (2 complete
and 2 incomplete) (Table 1). Complete technical success
was achieved in six cases (28.6%); all of these were in the
main trunk. Partial technical success was achieved in 15
cases (71.4%, Fig. 1); 11 of these were in the main trunk,
and four were in branches. Aspiration alone was effective in
seven cases, and additional thrombolysis was required in
the remaining 14 patients. Prostaglandin E1 (10 mg) was
administered intra-arterially in 17 cases. One patient with
severe main trunk atherosclerotic stenosis also received a
self-expandable stent (Acculink Carotid Stent System; AbbotLaboratories, Abbott Park, IL, USA). Despite these successful
endovascular procedures, ﬁve patients (all with main SMA
trunk complete occlusion) had to undergo laparotomy
within 24 hours (8e24 hours), two for new tenderness and
rebound, and three for worsening abdominal tenderness
and rebound. Complete technical success had been ach-
ieved in one of these patients and partial technical success,
in the remaining four. Small bowel resection was required in
all cases because of necrosis. The average length of the
resected bowel was 93 cm (range, 20e135 cm). A second-
look laparotomy was performed in one patient at 34
hours, but no further bowel resection was required.
Clinical follow-up revealed a 30-day mortality rate of
9.5% (2 of 21 patients). One patient died of acute respira-
tory distress syndrome 2 days after the endovascular pro-
cedure, and another died of sepsis and acute renal failure 4
days after the procedure. Over a median follow-up of 26
months (range, 8e78 months), abdominal symptoms
completely resolved in 15 patients. CTA was performed in
three patients (2 of whom exhibited atherosclerosis of the
SMA before the procedure) who presented with recurrent
abdominal pain, and all of these patients were found to
have moderate stenosis at the main trunk of the SMA. One
patient who underwent laparotomy exhibited temporary
short-bowel syndrome that resolved after 8 months. The
patient in whom a stent was placed was symptom-free at 9
months. One patient had a cerebral infarction 12 months
after the endovascular procedure. There was no recurrence
of SMA occlusion in any of the patients over the follow-up
period.
DISCUSSION
Acute thromboembolic occlusion of SMA is associated with
a high rate of morbidity and mortality despite many im-
provements in the diagnosis and treatment of this condi-
tion.1,6 Early diagnosis and immediate treatment are the
most important factors in the attempt to reverse ischemia
in the intestine.7,10 Our study demonstrates that early
endovascular therapy can lead to improved outcomes in
patients with this condition, with 30-day mortality of 9.5%.
Clinical diagnosis of early SMA occlusion is difﬁcult
because of the lack of a speciﬁc presentation. A typical
symptom is sudden-onset abdominal pain that is out of
proportion on physical ﬁndings. All of the patients in our
study presented with this type of abdominal pain. Another
important diagnostic factor is serum D-dimer level, which
has demonstrated high sensitivity for SMA occlusion.11 In
this study, 66.7% (14/21) of our cases had elevated D-dimer
levels on admission. Similarly, Acosta et al.12 reported that
elevated serum troponin I (TnI) levels are frequently asso-
ciated with acute SMA occlusion.
In patients at high risk for thromboembolic disease, with
a history of AF, signiﬁcant atherosclerotic disease, or pe-
ripheral arterial embolic disease, further evaluation is
needed.13 CTA allows for early diagnosis of thromboembolic
occlusion of SMA and facilitates early intervention. Menke14
reported that CT has a high sensitivity (93.3%) and speci-
ﬁcity (95.9%) for the diagnosis of acute mesenteric
Table 1. Clinical characteristics, treatments, and outcomes of acute thromboembolic SMA occlusion in 21 patients.
No. Age/
sex
Symptom Atherosclerosis Location Occlusion Onset
(h)
Treatment Technical
success
TTL (h) LBR (cm) Follow-up Outcome
1 77/M AP No atherosclerosis Branch >90% 5.5 Aspiration Partial No laparotomy No bowel resection 78 mo Completely recovered
2 59/M AP No atherosclerosis Trunk 75e90% 8 Aspiration, thrombolysis Partial No laparotomy No bowel resection 60 mo Completely recovered
3 74/M AP Aorta Branch Complete 2 Aspiration Partial No laparotomy No bowel resection 50 mo Cerebral infarction after
12 mo
4 67/M AP No atherosclerosis Trunk >90% 3 Aspiration Complete No laparotomy No bowel resection 50 mo Completely recovered
5 76/F AP No atherosclerosis Trunk >90% 5 Aspiration, thrombolysis Partial No laparotomy No bowel resection 48 mo Occasional AP
6 69/M AP Aorta Trunk 75e90% 9 Aspiration Complete No laparotomy No bowel resection 43 mo Completely recovered
7 81/M AP No atherosclerosis Branch >90% 14.5 Aspiration, thrombolysis Partial No laparotomy No bowel resection 36 mo Completely recovered
8 69/M AP No atherosclerosis Trunk Complete 10 Aspiration, thrombolysis,
laparotomy
Complete 10 135 28 mo Short bowel syndrome
9 74/F AP No atherosclerosis Branch Complete 8 Aspiration Partial No laparotomy No bowel resection 28 mo Completely recovered
10 59/M AP No atherosclerosis Trunk 75e90% 16.5 Aspiration, thrombolysis Complete No laparotomy No bowel resection 26 mo Completely recovered
11 64/M AP,
ATR
No atherosclerosis Trunk Complete 10 Aspiration, thrombolysis,
laparotomy
Partial 8 20 24 mo Completely recovered
12 73/F AP No atherosclerosis Trunk 75e90% 13 Aspiration, thrombolysis Partial No laparotomy No bowel resection 24 mo Completely recovered
13 87/M AP No atherosclerosis Trunk >90% 7 Aspiration Partial No laparotomy No bowel resection 18 mo Completely recovered
14 79/M AP No atherosclerosis Trunk Complete 9 Aspiration, thrombolysis,
laparotomy
Partial 16 65 16 mo Completely recovered
15 63/F AP No atherosclerosis Trunk 75e90% 18 Aspiration, thrombolysis Partial No laparotomy No bowel resection 14 mo Completely recovered
16 76/M AP,
ATR
No atherosclerosis Trunk Complete 10.5 Aspiration, thrombolysis,
laparotomy
Partial 24 130 2 d Died
17 79/M AP No atherosclerosis Trunk 75e90% 9.5 Aspiration, thrombolysis Partial No laparotomy No bowel resection 14 mo Completely recovered
18 68/M AP Aorta, SMA Trunk >90% 7 Aspiration Complete No laparotomy No bowel resection 12 mo Occasional AP
19 62/F AP,
ATR
No atherosclerosis Trunk Complete 9 Aspiration, thrombolysis,
laparotomy
Partial 22 115 4 d Died
20 54/M AP Aorta, SMA Trunk >90% 5.5 Aspiration, thrombolysis,
stent
Partial No laparotomy No bowel resection 9 mo Completely recovered
21 71/M AP Aorta, SMA Trunk >90% 2.5 Aspiration, thrombolysis Complete No laparotomy No bowel resection 8 mo Occasional AP
AP ¼ abdominal pain; ATR ¼ abdominal tenderness and rebound; d ¼ day; LBR ¼ length of bowel resection; mo ¼ month; SMA ¼ superior mesenteric artery; TTL ¼ time to laparotomy.
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Figure 1. A 64-year-old man (case 11) presented with acute-onset abdominal pain that had begun 6 hours before presentation. (a) Computed
tomography angiography (CTA) of the abdomen demonstrated abrupt occlusion of the superior mesenteric artery (SMA) 4.1 cm from the
origin (arrow). (b) An axial image demonstrated a large central luminal ﬁlling defect with minimal contrast at the edge (arrow). (c) Volume-
rendered CTA showed abrupt occlusion of the proximal SMA without collateral vessel. (d) Digital subtraction angiography (DSA) of the SMA
revealed an occlusion with a convesmeniscus, a typical sign for embolic occlusion (arrow). (e) After aspiration, themain trunk became patent,
but small emboli (black arrows) and vasospasms (white arrows)were identiﬁed in the branches. (f) Therewas complete restoration of the ﬂow
to one branch (white arrow) and partial reopening to another (black arrow) after a bolus of urokinase (200,000 units) was slowly injected over
20 minutes, followed by an infusion of prostaglandin E1 (10 mg). (g) The aspirated thromboemboli can be seen.
200 Z. Jia et al.ischemia, supporting the use of this technique as the ﬁrst-
line imaging method for suspected acute SMA occlusion.
In our study, all patients had positive ﬁndings on CTA that
were conﬁrmed on selective arteriography. CT can alsodemonstrate any late complications of bowel ischemia. CTA
is therefore the key study for diagnosing this condition and
determining whether the patient is a candidate for an
endovascular approach.
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tion of the viability of the gut with resection of any
nonviable bowel, has been the traditional treatment for
acute SMA occlusion. However, open surgery has a high
mortality rate.1,6 Furthermore, a satisfactory embolectomy
result may not be possible with surgery in certain condi-
tions, such as multiple or small branch emboli. Immediately
after surgery, anticoagulant therapy is contraindicated
because of concerns about bleeding, which plays an
important role in the management of thrombotic disease.
Percutaneous revascularization may be an effective
therapeutic alternative to surgical treatment in selected
patients.15 The main advantage of this technique is that it is
less invasive, carrying a low rate of procedure-related
mortality and morbidity.16,17 Whereas previous research
has demonstrated a surgical mortality rate of 59% (range,
31e78%),1,6,7 patients in our study had a 30-day mortality
rate of 9.5%. The morbidity rate was also low, with only one
patient (4.8% [1/21]) exhibiting temporary short-bowel
syndrome. Arthurs et al.18 reported that endovascular
therapy also results in lower laparotomy rates, signiﬁcantly
less amount of bowel resection in surgical exploration, and
fewer complications caused by renal or pulmonary failure.
Additionally, endovascular therapy may be safe and effec-
tive for cases of peripheral and segmental occlusions or
severe atherosclerosis, conditions in which surgical revas-
cularization may be challenging.17 Heiss et al.19 suggested
that endovascular treatment of SMA occlusion with peri-
toneal signs but no signs of bowel wall perforation might
also be an option if surgical revascularization of the SMA is
deemed unsuitable because of associated comorbidities, or
if surgery will be delayed because an operating room or
surgeon is not available.
The drawback of percutaneous revascularization is that
the viability of the bowel structure cannot be assessed, and
delayed diagnosis of bowel necrosis may increase morbidity
and mortality. Therefore, appropriate selection of patients is
important so that therapy is not delayed in patients with
necrotic bowel. Our study also demonstrated that technical
success in re-establishing SMA ﬂow may not necessarily
prevent occurrences of irreversible bowel ischemia and
subsequent sepsis, shock, or even death.
In this study, three patients had abdominal tenderness
and rebound on physical examination before endovascular
therapy, with no CT evidence of bowel perforation or ne-
crosis; these patients required laparotomy because of
worsening bowel ischemia even after successful endovas-
cular revascularization. In addition, two patients developed
new symptoms of advanced bowel ischemia after endo-
vascular therapy. All ﬁve of these patients had complete
occlusion at the main trunk, indicating that the irreversible
bowel ischemia occurs more often in those patients with
complete occlusion of SMA main trunk.
Acute SMA thromboembolic disease can be associated
with age, severe atherosclerotic disease, and AF.20e22 The
occlusion can be caused by a single embolus or multiple
emboli consisting of simple thrombosis, organized clot, or
atherosclerotic plaque.We believe that aspiration should beattempted ﬁrst to remove the embolus and re-establish vital
ﬂow to the small bowel regardless of the composition of the
emboli. Pharmacologic thrombolysis can assist when me-
chanical embolectomy is incomplete if the emboli consist
predominantly of thrombosis. Arthurs et al.18 reported that
endovascular results are not correlated with the etiology of
thromboemboli or the location of occlusion, but complete
occlusions appeared to have a lower success rate than
partial occlusions, results which were conﬁrmed in our
study. It is our experience that removal of the throm-
boemboli at the SMA trunk with a 6-Fr guiding catheter is
much easier than removal in the branch arteries with a 5-Fr
catheter. Therefore, residual thromboemboli in the SMA
branches were seen more frequently than in the main trunk
after aspiration. Fortunately, because the marginal arteries
provide essential collaterals to maintain sufﬁcient blood
ﬂow distally, it is not absolutely necessary to achieve
complete restoration of blood ﬂow in the branches. Ryer
et al.23 reported that severe atherosclerosis can be used as
a predictor for poor outcome after endovascular treatment,
and this was conﬁrmed in our study. In patients with severe
atherosclerosis, SMA narrowing may be caused by the un-
derlying plaques, and acute occlusion may result from
reduced ﬂow. Therefore, a self-expanding stent placement is
most appropriate after thrombectomy and/or thrombolysis
in these patients.
Yun et al.6 reported a low bleeding risk when anti-
coagulation with low molecular weight heparin was initi-
ated 2 to 3 days after surgery; patients could then be
converted to an oral vitamin K antagonist. In our study, low
molecular weight heparin was administered routinely for 3
days, with the option of switching to warfarin if abdominal
pain had resolved. We believe that the presence of
abdominal pain is an important indicator of ongoing bowel
ischemia, suggesting that the patient may require surgery. If
such pain is absent, oral warfarin can safely be initiated. Our
suggested treatment algorithm for acute thromboembolic
occlusion of the SMA is outlined in Fig. 2.
The major limitation of this study was its retrospective
nature, which did not allow for direct comparison with
other treatment strategies. The sample size was also rela-
tively small, with selection bias in our study population.
Most of the patients who presented with advanced signs
and symptoms of bowel ischemia were excluded from this
study because of concerns over delaying treatment. Finally,
most of our patients had incomplete rather than complete
occlusion, which may have contributed to the positive
outcomes.CONCLUSION
Percutaneous endovascular therapy is a promising alterna-
tive to surgical revascularization for the treatment of acute
SMA occlusion in selected patients. Early diagnosis with CTA
followed by immediate endovascular intervention is the key
to positive outcomes in these patients. Close postprocedure
monitoring is also necessary, with laparotomy performed
early in patients who develop new or worsening signs of
Figure 2. The treatment algorithm for acute thromboembolic occlusion of the SMA.
202 Z. Jia et al.peritonism after the endovascular procedure, particularly in
those who had complete occlusion of the main trunk of the
SMA.
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